Universe Pharmaceuticals INC Financing Cash Flow
Universe Pharmaceuticals INC (UPC) reported Financing Cash Flow of $9.73 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-01-29
| Period end | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $9.73B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $33.95B 20-F · filed 2026-01-29 | $33.95M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $6.07M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | -$1.39B 20-F · filed 2026-01-29 | -$1.39M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $2.08M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $3.32M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | -$19.99K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $26.58M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $24.14M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $470.14K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | -$16.00M 20-F · filed 2022-01-31 |